Galen Witt

428 total citations
15 papers, 334 citations indexed

About

Galen Witt is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology. According to data from OpenAlex, Galen Witt has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Galen Witt's work include Pharmaceutical studies and practices (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Galen Witt is often cited by papers focused on Pharmaceutical studies and practices (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Galen Witt collaborates with scholars based in United States and United Kingdom. Galen Witt's co-authors include G. Richard Granneman, John H. Cavanaugh, Akhteruzzaman Molla, Keith Erdman, J. Girault, J Decourt, C. Locke, Walid M. Awni, Jr. Smith and John M. Leonard and has published in prestigious journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and The American Journal of Gastroenterology.

In The Last Decade

Galen Witt

15 papers receiving 324 citations

Peers

Galen Witt

PPCH

VIROL

PMH

PHARM

C. Locke United States

Bani Tamraz United States

Jutta Miller United States

Roselyne Bidault France

Carole Giraud France

P Fischer United States

Toni M Dando

David Hoelscher United States

Aziz Laurent United States

Baralee Punyawudho Thailand

C. Locke United States

Galen Witt

132 ×1.1

98 ×0.9

PPCH

83 ×1.2

VIROL

51 ×0.8

PMH

91 ×1.4

PHARM

Citations per year, relative to Galen Witt Galen Witt (= 1×) peers C. Locke

Countries citing papers authored by Galen Witt

Since Specialization

Citations

This map shows the geographic impact of Galen Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen Witt more than expected).

Fields of papers citing papers by Galen Witt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galen Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen Witt. The network helps show where Galen Witt may publish in the future.

Co-authorship network of co-authors of Galen Witt

This figure shows the co-authorship network connecting the top 25 collaborators of Galen Witt. A scholar is included among the top collaborators of Galen Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galen Witt. Galen Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Shaheen, Nicholas J., David A. Peura, María Claudia Pérez, et al.. (2008). Impact of Baseline La Grade on Healing of Erosive Esophagitis (EE) Following Treatment with TAK-390MR, a Proton Pump Inhibitor (PPI) with a Novel Dual Delayed Release Formulation, Compared with Lansoprazole (Lan). The American Journal of Gastroenterology. 103. S10–S11. 1 indexed citations

Zhang, Weijiang, et al.. (2008). Age-Dependent Pharmacokinetics of Lansoprazole in Neonates and Infants. Pediatric Drugs. 10(4). 265–274. 21 indexed citations

Mayer, Michael D., Majid Vakily, Galen Witt, & Darcy J. Mulford. (2008). S1095 The Pharmacokinetics of TAK-390mr 60 mg, a Dual Delayed Release Formulation of the Proton Pump Inhibitor TAK-390, and Lansoprazole 60 mg: A Retrospective Analysis. Gastroenterology. 134(4). A–176. 11 indexed citations

Wu, Jing, Majid Vakily, Galen Witt, & Darcy J. Mulford. (2007). TAK-390MR vs. Lansoprazole (LAN) for Maintenance of Drug Concentration above a Threshold Which Corresponds to Higher%-Time pH > 4. The American Journal of Gastroenterology. 102. S124–S124. 5 indexed citations

Mayer, Michael D., Darcy J. Mulford, & Galen Witt. (2000). Effect of hepatic impairment on the pharmacokinetics of cefditoren. 40. 12. 3 indexed citations

Gustavson, Linda E., et al.. (1998). Lack of a Clinically Significant Pharmacokinetic Drug Interaction Between Tiagabine and Valproate. American Journal of Therapeutics. 5(2). 73–80. 16 indexed citations

Wong, Shekman, Jeffrey Drajesk, Min S. Chang, Galen Witt, & Walid M. Awni. (1998). Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers. Biopharmaceutics & Drug Disposition. 19(3). 159–162. 4 indexed citations

Wong, Shekman, Jeffrey Drajesk, Min S. Chang, et al.. (1998). Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers. Clinical Pharmacology & Therapeutics. 63(3). 324–331. 7 indexed citations

Samara, Emil, Richard Granneman, Galen Witt, & John H. Cavanaugh. (1997). Effect of Valproate on the Pharmacokinetics and Pharmacodynamics of Lorazepam. The Journal of Clinical Pharmacology. 37(5). 442–450. 32 indexed citations

10.

Hsu, Ann, G. Richard Granneman, Galen Witt, et al.. (1997). Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects. Antimicrobial Agents and Chemotherapy. 41(5). 898–905. 158 indexed citations

11.

Granneman, G. Richard, Dennis W. Schneck, John H. Cavanaugh, & Galen Witt. (1996). Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium.. PubMed. 57(5). 204–6. 26 indexed citations

12.

Awni, Walid M., John H. Cavanaugh, Galen Witt, G. Richard Granneman, & Louise M. Dubé. (1995). The Effect of Food on the Pharmacokinetics of Zileuton. Clinical Pharmacokinetics. 29(Supplement 2). 62–66. 8 indexed citations

13.

Awni, Walid M., Rene A. Braeckman, G. Richard Granneman, Galen Witt, & Louise M. Dubé. (1995). Pharmacokinetics and Pharmacodynamics of Zileuton after Oral Administration of Single and Multiple Dose Regimens of Zileuton 600mg in Healthy Volunteers. Clinical Pharmacokinetics. 29(Supplement 2). 22–33. 30 indexed citations

14.

Awni, Walid M., et al.. (1995). Pharmacokinetic Interactions between Zileuton and Prednisone. Clinical Pharmacokinetics. 29(Supplement 2). 105–111. 10 indexed citations

15.

Chun, Alexander, Janet E. Lamm, Galen Witt, & John H. Cavanaugh. (1995). Multiple-Dose Evaluation of the Absorption Characteristics of Divalproex Sodium Tablets, a Delayed-Release Preparation of Valproate, in Healthy Volunteers. Clinical Drug Investigation. 10(1). 40–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact